ARCHIVES

Opdivo Study Shows 41 Percent One-Year Survival In Patients With at Least Two Past Therapies

This article is from The Cancer Letter archive.

Vol. 37 No. 11 | November 28, 2014

Download PDF Visit The Full Archive

Related Articles

SWOG Launching New Study Based on Recurrence Test Scores

April 29, 2011

Wyden Plans Bill To Induce Drug Firms to conduct Trials

October 29, 1993

NCI Program: DOD’s TRICARE To Cover Patient Costs In NCI Prevention, Early detection Trials

September 10, 1999

Cancer Groups Endorse Pazdur For FDA Commissioner.

January 19, 2001

FDA Proposes To Drop Specific Requirements For Reprint Distribution On Off-Label Uses.

February 22, 2008

PET Three Months After Therapy Provides Early Warning Of Need For Intervention

November 30, 2007